Introduction The development of new compounds in recent decades has substantially improved the pharmacotherapy of type 2 diabetes (T2D) by improving achievement of metabolic targets while mitigating specific side effects (e.g., weight gain, hypoglycemia) frequently observed in patients treated with traditional hypoglycemic drugs such as insulin and sulfonylureas
Nora Volkow, also said retrospective analyses of electronic health records showed patients with diabetes who were prescribed GLP-1 drugs such as semaglutide had significantly better health outcomes related to cannabis use disorder, compared with those on other diabetes treatments
Zinc + B-Complex Boost 4
Additionally, a modified anthracycline, N-Benzyladriamycin-14-valerate (AD 198), showed protective effects against DOX-induced cardiomyopathy in rats by attenuating molecular changes and preserving left ventricular function [165]
Mittman, PhD, of the Department of Research & Evaluation
In rare cases, some people may experience serious side effects like hypoglycemia, pancreatitis, gallbladder disease, kidney disease, and increased heart rate